2009
DOI: 10.1016/j.tracli.2009.09.004
|View full text |Cite
|
Sign up to set email alerts
|

HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: Lower rates among volunteer blood donors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
45
8
8

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(66 citation statements)
references
References 8 publications
5
45
8
8
Order By: Relevance
“…It would be necessary to wait for the evolution of this seroprevalence in the following years to make the judgment. However, we believe that on the whole, this fluctuating behavior would be influenced by family donors known as donors at risk of transfusion-transmitted infection (TTIs) [32] [40] [41] [51].…”
Section: /15mentioning
confidence: 99%
“…It would be necessary to wait for the evolution of this seroprevalence in the following years to make the judgment. However, we believe that on the whole, this fluctuating behavior would be influenced by family donors known as donors at risk of transfusion-transmitted infection (TTIs) [32] [40] [41] [51].…”
Section: /15mentioning
confidence: 99%
“…Según la OMS, la sangre donada por voluntarios altruistas es más segura que la sangre de donantes de reposición. Al respecto, un estudio en Mali muestra que la positividad para HBsAg fue significativamente mayor en las unidades de sangre recolectadas de los donantes de reemplazo que los donantes voluntarios (p<0,001) y la positividad para VHC y HBsAg fue significativamente mayor (p<0,001) en unidades de sangre recolectadas de nuevos donantes que los donantes regulares (14) . En Guinea, la prevalencia de HBsAg confirmados fue significativamente menor en los donantes de reemplazo o en donantes familiares que en los donantes voluntarios por primera vez (p<0,001 y p=0,04, respectivamente) (15) .…”
Section: Discussionunclassified
“…Comparing the seroprevalency of transfusion transmissible infections in RD and VD was the subject of numerous studies worldwide [4,[11][12][13][14][15][16][17][18][19][20] and the results were different depending on the serological marker studied and countries. Many studies have been criticized for having found a higher seroprevalency in RD compared to VD without taking into consideration the status of the donor: new VD or regular VD (regular VD can skew the results as they had serological tests earlier) nor the heterogeneity of age and sex of the two donor groups compared [2,12].…”
Section: Discussionmentioning
confidence: 99%